SCHEMBL5889494

SCHEMBL5889494

O=C(O)c1ccc(C(=O)Oc2c(F)c(F)c(F)c(F)c2F)s1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 6/20 0.50
PKM P14618 1/20 0.42
LIG1 P18858 1/20 0.42
NPSR1 Q6W5P4 2/20 0.39
LMNA P02545 1/20 0.39
PPARG P37231 1/20 0.39
NCOA2 Q15596 1/20 0.39
NCOA1 Q15788 1/20 0.39
NCOA3 Q9Y6Q9 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HPGD P15428 3/20 0.37
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
GAA P10253 1/20 0.37
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5889493 0.93 HDAC4 (0.42) DAONPSR1LMNAPPARGNCOA2
SCHEMBL5290034 0.82 DAO (0.50) DAOLMNAHDAC3HDAC4HDAC1
SCHEMBL28513694 0.81 CES2 (0.50) DAONPSR1LMNAPPARGNCOA2
SCHEMBL5889507 0.79 NPSR1 (0.41) NPSR1LMNAPPARGNCOA2NCOA1
SCHEMBL5966698 0.79 RAB9A (0.53) PPARGNCOA2NCOA1NCOA3HDAC1
SCHEMBL1303016 0.77 NPSR1 (0.60) DAOPKMLIG1NPSR1LMNA
SCHEMBL6294073 0.74 DAO (0.58) DAOPKMLIG1NPSR1LMNA
SCHEMBL8543811 0.74 HPGD (0.47) DAOHPGDALDH1A1KDM4EMEN1
Hydrazine SCHEMBL27261279 0.73 NPSR1 (0.56) DAOPKMLIG1NPSR1LMNA
SCHEMBL70493 0.73 DAO (0.67) DAOPKMLIG1HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7064218-B2 Aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity GENELABS TECHNOLOGIES, INC. (US) 2006-06-20 US disclosed
US-20030212113-A1 Novel aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity GLAXOSMITHKLINE LLC 2003-11-13 US disclosed
WO-2003057212-A1 POLYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL, ANTIFUNGAL OR ANTITUMOR ACTIVITY GENELABS TECHNOLOGIES, INC. (US) 2003-07-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212113-A1 Novel aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity TYR, CYP51A1, ODC1 DAO 369/4885PKM 1922/4885LIG1 2950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.